PUBLISHER: KBV Research | PRODUCT CODE: 1473108
PUBLISHER: KBV Research | PRODUCT CODE: 1473108
North America Testosterone Replacement Therapy Market Size, Share & Trends Analysis Report By End User (Clinics, and Hospital), By Product Type (Injectables, Topical, and Others), By Active, By Country and Growth Forecast, 2024 - 2031
The North America Testosterone Replacement Therapy Market would witness market growth of 3.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Testosterone Replacement Therapy Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $734.8 million by 2031. The Canada market is experiencing a CAGR of 5.8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 4.9% during (2024 - 2031).
Professional organizations and medical societies have developed guidelines and recommendations for the diagnosis and management of hypogonadism. These guidelines provide evidence-based approaches to TRT initiation, monitoring, and dose adjustment, helping healthcare providers make informed treatment decisions and optimize patient outcomes. Also, healthcare providers, patient advocacy groups, and pharmaceutical companies have undertaken efforts to raise awareness about hypogonadism and the benefits of TRT. Increased awareness has led to higher rates of diagnosis and treatment initiation among affected individuals who may have previously been unaware of their condition or hesitant to seek medical attention for their symptoms.
Additionally, the testosterone replacement therapy market is influenced by various trends that shape its landscape, including advancements in treatment options, evolving patient preferences, regulatory changes, and shifts in healthcare delivery models. For example, there is a growing trend towards personalized medicine in the testosterone replacement therapy market, with healthcare providers adopting individualized treatment approaches based on patient-specific factors such as age, symptoms, comorbidities, and treatment goals. Personalized medicine allows for tailored TRT regimens, including the selection of appropriate formulations, dosages, and administration routes, to optimize therapeutic outcomes and minimize side effects for each patient.
Smoking is associated with lower testosterone levels in men, which can contribute to the development of hypogonadism or testosterone deficiency. As smoking rates increase in Canada, there may be a corresponding rise in the prevalence of hypogonadism among male smokers. This increase in the number of individuals with testosterone deficiency could lead to greater demand for TRT to address hormone imbalances and associated symptoms. Therefore, the high rates of smokers and the prevalence of obesity is propelling the growth of the market.
Based on End User, the market is segmented into Clinics, and Hospital. Based on Product Type, the market is segmented into Injectables, Topical, and Others. Based on Active ingredients, the market is segmented into Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Endo International PLC
- AbbVie, Inc.
- Pfizer, Inc.
- Eli Lilly And Company
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Ferring Holdings SA
- Marius Pharmaceuticals LLC
- Besins Healthcare Monaco S.A.M.
- Acrux Limited
North America Testosterone Replacement Therapy Market Report Segmentation
By End User
- Clinics
- Hospital
By Product Type
- Injectables
- Topical
- Others
By Active ingredient
- Testosterone Cypionate
- Testosterone Undecanoate
- Testosterone Enanthate
- Testosterone
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1North America Testosterone Replacement Therapy Market, by End User
- 1.4.2North America Testosterone Replacement Therapy Market, by Product Type
- 1.4.3North America Testosterone Replacement Therapy Market, by Active ingredient
- 1.4.4North America Testosterone Replacement Therapy Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.North America Testosterone Replacement Therapy Market by End User
- 4.1North America Clinics Market by Region
- 4.2North America Hospital Market by Region
Chapter 5.North America Testosterone Replacement Therapy Market by Product Type
- 5.1North America Injectables Market by Country
- 5.2North America Topical Market by Country
- 5.3North America Others Market by Country
Chapter 6.North America Testosterone Replacement Therapy Market by Active ingredients
- 6.1North America Testosterone Cypionate Market by Country
- 6.2North America Testosterone Undecanoate Market by Country
- 6.3North America Testosterone Enanthate Market by Country
- 6.4North America Testosterone Market by Country
- 6.5North America Others Market by Country
Chapter 7.North America Testosterone Replacement Therapy Market by Country
- 7.1US Testosterone Replacement Therapy Market
- 7.1.1US Testosterone Replacement Therapy Market by End User
- 7.1.2US Testosterone Replacement Therapy Market by Product Type
- 7.1.3US Testosterone Replacement Therapy Market by Active ingredients
- 7.2Canada Testosterone Replacement Therapy Market
- 7.2.1Canada Testosterone Replacement Therapy Market by End User
- 7.2.2Canada Testosterone Replacement Therapy Market by Product Type
- 7.2.3Canada Testosterone Replacement Therapy Market by Active ingredients
- 7.3Mexico Testosterone Replacement Therapy Market
- 7.3.1Mexico Testosterone Replacement Therapy Market by End User
- 7.3.2Mexico Testosterone Replacement Therapy Market by Product Type
- 7.3.3Mexico Testosterone Replacement Therapy Market by Active ingredients
- 7.4Rest of North America Testosterone Replacement Therapy Market
- 7.4.1Rest of North America Testosterone Replacement Therapy Market by End User
- 7.4.2Rest of North America Testosterone Replacement Therapy Market by Product Type
- 7.4.3Rest of North America Testosterone Replacement Therapy Market by Active ingredients
Chapter 8.Company Profiles
- 8.1Endo International PLC
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
- 8.2AbbVie, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
- 8.3Pfizer, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional & Segmental Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
- 8.3.5.1Acquisition and Mergers:
- 8.3.6SWOT Analysis
- 8.4Eli Lilly And Company
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional Analysis
- 8.4.4Research & Development Expenses
- 8.4.5Recent strategies and developments:
- 8.4.5.1Partnerships, Collaborations, and Agreements:
- 8.4.6SWOT Analysis
- 8.5Teva Pharmaceutical Industries Ltd.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
- 8.6Amneal Pharmaceuticals, Inc.
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental Analysis
- 8.6.4Research & Development Expenses
- 8.6.5SWOT Analysis
- 8.7Ferring Holdings SA
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research and Development Expense
- 8.7.5SWOT Analysis
- 8.8Marius Pharmaceuticals LLC
- 8.8.1Company Overview
- 8.8.2Recent strategies and developments:
- 8.8.2.1Trials & Approvals:
- 8.9Besins Healthcare Monaco S.A.M.
- 8.9.1Company Overview
- 8.9.2Recent strategies and developments:
- 8.9.2.1Geographical Expansions:
- 8.10.Acrux Limited
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis
LIST OF TABLES
- TABLE 1North America Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
- TABLE 2North America Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
- TABLE 3North America Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
- TABLE 4North America Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
- TABLE 5North America Clinics Market by Region, 2020 - 2023, USD Million
- TABLE 6North America Clinics Market by Region, 2024 - 2031, USD Million
- TABLE 7North America Hospital Market by Region, 2020 - 2023, USD Million
- TABLE 8North America Hospital Market by Region, 2024 - 2031, USD Million
- TABLE 9North America Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
- TABLE 10North America Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
- TABLE 11North America Injectables Market by Country, 2020 - 2023, USD Million
- TABLE 12North America Injectables Market by Country, 2024 - 2031, USD Million
- TABLE 13North America Topical Market by Country, 2020 - 2023, USD Million
- TABLE 14North America Topical Market by Country, 2024 - 2031, USD Million
- TABLE 15North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 16North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 17North America Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
- TABLE 18North America Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
- TABLE 19North America Testosterone Cypionate Market by Country, 2020 - 2023, USD Million
- TABLE 20North America Testosterone Cypionate Market by Country, 2024 - 2031, USD Million
- TABLE 21North America Testosterone Undecanoate Market by Country, 2020 - 2023, USD Million
- TABLE 22North America Testosterone Undecanoate Market by Country, 2024 - 2031, USD Million
- TABLE 23North America Testosterone Enanthate Market by Country, 2020 - 2023, USD Million
- TABLE 24North America Testosterone Enanthate Market by Country, 2024 - 2031, USD Million
- TABLE 25North America Testosterone Market by Country, 2020 - 2023, USD Million
- TABLE 26North America Testosterone Market by Country, 2024 - 2031, USD Million
- TABLE 27North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 28North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 29North America Testosterone Replacement Therapy Market by Country, 2020 - 2023, USD Million
- TABLE 30North America Testosterone Replacement Therapy Market by Country, 2024 - 2031, USD Million
- TABLE 31US Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
- TABLE 32US Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
- TABLE 33US Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
- TABLE 34US Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
- TABLE 35US Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
- TABLE 36US Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
- TABLE 37US Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
- TABLE 38US Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
- TABLE 39Canada Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
- TABLE 40Canada Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
- TABLE 41Canada Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
- TABLE 42Canada Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
- TABLE 43Canada Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
- TABLE 44Canada Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
- TABLE 45Canada Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
- TABLE 46Canada Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
- TABLE 47Mexico Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
- TABLE 48Mexico Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
- TABLE 49Mexico Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
- TABLE 50Mexico Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
- TABLE 51Mexico Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
- TABLE 52Mexico Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
- TABLE 53Mexico Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
- TABLE 54Mexico Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
- TABLE 55Rest of North America Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
- TABLE 56Rest of North America Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
- TABLE 57Rest of North America Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
- TABLE 58Rest of North America Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
- TABLE 59Rest of North America Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
- TABLE 60Rest of North America Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
- TABLE 61Rest of North America Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
- TABLE 62Rest of North America Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
- TABLE 63Key Information - Endo International PLC
- TABLE 64Key information - AbbVie, Inc.
- TABLE 65Key Information - Pfizer, Inc.
- TABLE 66Key Information - Eli Lilly And Company
- TABLE 67Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 68Key Information - Amneal Pharmaceuticals, INc.
- TABLE 69key information - Ferring Holdings SA
- TABLE 70Key Information - Marius Pharmaceuticals LLC
- TABLE 71Key Information - Besins Healthcare Monaco S.A.M.
- TABLE 72Key Information - Acrux Limited
